Skip to Content
Merck
  • Hepatic stimulator substance inhibits calcium overflow through the mitochondria-associated membrane compartment during nonalcoholic steatohepatitis.

Hepatic stimulator substance inhibits calcium overflow through the mitochondria-associated membrane compartment during nonalcoholic steatohepatitis.

Laboratory investigation; a journal of technical methods and pathology (2016-12-20)
Fan Xiao, Jing Zhang, Can Zhang, Wei An
ABSTRACT

Nonalcoholic fatty liver disease is considered a disorder of the endoplasmic reticulum (ER) and mitochondria. Recent studies have shown that the ER and mitochondrial membranes overlap by 15-20%, a region referred to as the 'mitochondria-associated ER membrane' (MAM). Some proteins, including sarco/ER calcium ATPase (SERCA), are located in the MAM and have an important role in Ca

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
o-Phenetidine, ≥97.0% (GC)